Calavo's Q1 results were disappointing with significant misses on revenue and EPS estimates. The company's performance has been affected by market dynamics within its avocado business. The company's revenue has been declining over the last three years, which is among the worst in the consumer staples industry.
A GameStop GME$游戏驿站(GME.US)$director just made the first open-market stock purchase this year, while the CEOs of department-store chain Kohl’s KSS +5.21%$柯尔百货(KSS.US)$and avocado slinger Calavo Growers$卡拉沃养殖(CVGW.US)$picked up millions of dollars of stock.
As the first quarter came to a close, some company insiders bought up shares on the open market. A GameStop$游戏驿站(GME.US)$director just made the first open-market stock purchase this year, while the CEOs of department-store chain Kohl’s$柯尔百货(KSS.US)$and avocado slinger Calavo Growers CVGW$卡拉沃养殖(CVGW.US)$picked up millions of dollars of stock.
Gainers: •$Okta(OKTA.US)$+15.8% (In reaction to earnings) •$StoneCo(STNE.US)$+12.9% (In reaction to earnings) •$Turning Point Therapeutics(TPTX.US)$+116.8% (Bristol Myers Squibb (BMY) will acquire Turning Point Therapeutics for $76,00 per share; expected to be accretive to Non-GAAP earnings per share beginningin2025) •$Amylyx Pharmaceuticals(AMLX.US)$+24.9% (receives PDUFA date extension for AMX0035; scheduled for September ...
卡拉沃养殖股票讨论区
A GameStop $游戏驿站(GME.US)$ director just made the first open-market stock purchase this year, while the CEOs of department-store chain Kohl’s $柯尔百货(KSS.US)$ and avocado slinger Calavo Growers CVGW $卡拉沃养殖(CVGW.US)$ picked up millions of dollars of stock.
• $Okta(OKTA.US)$ +15.8% (In reaction to earnings)
• $StoneCo(STNE.US)$ +12.9% (In reaction to earnings)
• $Turning Point Therapeutics(TPTX.US)$ +116.8% (Bristol Myers Squibb (BMY) will acquire Turning Point Therapeutics for $76,00 per share; expected to be accretive to Non-GAAP earnings per share beginningin2025)
• $Amylyx Pharmaceuticals(AMLX.US)$ +24.9% (receives PDUFA date extension for AMX0035; scheduled for September ...
暂无评论